213 related articles for article (PubMed ID: 30792255)
21. Trametinib (GSK1120212) in the treatment of melanoma.
Salama AK; Kim KB
Expert Opin Pharmacother; 2013 Apr; 14(5):619-27. PubMed ID: 23432625
[TBL] [Abstract][Full Text] [Related]
22. Symptomatic neurocutaneous melanosis: mild clinical onset in a teenager.
Vanood A; Lee YA; Leleszi E; Krishnan A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257354
[TBL] [Abstract][Full Text] [Related]
23. Congenital melanocytic nevi: treatment modalities and management options.
Marghoob AA; Borrego JP; Halpern AC
Semin Cutan Med Surg; 2003 Mar; 22(1):21-32. PubMed ID: 12773011
[TBL] [Abstract][Full Text] [Related]
24. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
Molho-Pessach V; Hartshtark S; Merims S; Lotem M; Caplan N; Alfassi H; Maly A; Goldstein G; Muskatel RS
Br J Dermatol; 2022 Dec; 187(6):1052-1054. PubMed ID: 36030465
[No Abstract] [Full Text] [Related]
25. Medium-sized congenital melanocytic nevus of the forehead, glabella and temple surgical treatment and long-term follow-up.
Goldman A; Wollina U; Tchernev G; Chokoeva AA; Lotti T
J Biol Regul Homeost Agents; 2016; 30(2 Suppl 2):53-8. PubMed ID: 27373136
[TBL] [Abstract][Full Text] [Related]
26. Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway Inhibition.
Martin SB; Polubothu S; Bruzos AL; Kelly G; Horswell S; Sauvadet A; Bryant D; Zecchin D; Riachi M; Michailidis F; Sadri A; Muwanga-Nanyonjo N; Lopez-Balboa P; Knöpfel N; Bulstrode N; Pittman A; Yeh I; Kinsler VA
J Invest Dermatol; 2024 Mar; 144(3):593-600.e7. PubMed ID: 37716647
[TBL] [Abstract][Full Text] [Related]
27. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
[TBL] [Abstract][Full Text] [Related]
28. Laser treatment of congenital nevi.
Ferguson RE; Vasconez HC
J Craniofac Surg; 2005 Sep; 16(5):908-14. PubMed ID: 16192881
[TBL] [Abstract][Full Text] [Related]
29. Giant congenital melanocytic nevi: the significance of neurocutaneous melanosis in neurologically asymptomatic children.
Foster RD; Williams ML; Barkovich AJ; Hoffman WY; Mathes SJ; Frieden IJ
Plast Reconstr Surg; 2001 Apr; 107(4):933-41. PubMed ID: 11252085
[TBL] [Abstract][Full Text] [Related]
30. Tissue expansion in the treatment of giant congenital melanocytic nevi.
Maves MD; Lusk RP
Arch Otolaryngol Head Neck Surg; 1987 Sep; 113(9):987-91. PubMed ID: 3606851
[TBL] [Abstract][Full Text] [Related]
31. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
32. A Novel Treatment for Giant Congenital Melanocytic Nevi Combining Inactivated Autologous Nevus Tissue by High Hydrostatic Pressure and a Cultured Epidermal Autograft: First-in-Human, Open, Prospective Clinical Trial.
Morimoto N; Mitsui T; Sakamoto M; Mahara A; Yoshimura K; Arata J; Jinno C; Kakudo N; Kusumoto K; Yamaoka T
Plast Reconstr Surg; 2021 Jul; 148(1):71e-76e. PubMed ID: 34181614
[TBL] [Abstract][Full Text] [Related]
33. Xanthogranulomatous reaction to trametinib for metastatic malignant melanoma.
Min MS; Yao J; Chee N; Sapadin AN; Shim-Chang H
Cutis; 2018 Oct; 102(4):283-286. PubMed ID: 30489553
[TBL] [Abstract][Full Text] [Related]
34. Melanoma arising in a Giant congenital melanocytic nevus: two case reports.
Belysheva TS; Vishnevskaya YV; Nasedkina TV; Emelyanova MA; Abramov IS; Orlova KV; Lubchenko LN; Utyashev IA; Doroshenko MB; Demidov LV; Aliev MD
Diagn Pathol; 2019 Feb; 14(1):21. PubMed ID: 30782194
[TBL] [Abstract][Full Text] [Related]
35. Giant congenital nevus with progressive sclerodermoid reaction in a newborn.
Pattee SF; Hansen RC; Bangert JL; Joganic EF
Pediatr Dermatol; 2001; 18(4):320-4. PubMed ID: 11576407
[TBL] [Abstract][Full Text] [Related]
36. Giant congenital melanocytic nevi and malignant transformation: a case for early radical intervention.
Maguire CR; Livingston R; Phillips GE; Kimble RM
Pediatr Surg Int; 2017 Jul; 33(7):823-827. PubMed ID: 28508099
[TBL] [Abstract][Full Text] [Related]
37. [Removal of melanocytic nevi as a prophylaxis and early recognition of cutaneous and mucous malignant melanoma].
Kociałkowski K; Prazyński A; Urbański G; Gertig G
Ginekol Pol; 1993 Jan; 64(1):16-8. PubMed ID: 8359716
[TBL] [Abstract][Full Text] [Related]
38. Rhabdomyosarcoma arising in a congenital melanocytic nevus.
Hoang MP; Sinkre P; Albores-Saavedra J
Am J Dermatopathol; 2002 Feb; 24(1):26-9. PubMed ID: 11803277
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyosarcoma arising in a giant congenital melanocytic nevus.
Ilyas EN; Goldsmith K; Lintner R; Manders SM
Cutis; 2004 Jan; 73(1):39-43. PubMed ID: 14964630
[TBL] [Abstract][Full Text] [Related]
40. Tissue expansion in the treatment of giant congenital melanocytic nevi of the upper extremity.
Ma T; Fan K; Li L; Xie F; Li H; Chou H; Zhang Z
Medicine (Baltimore); 2017 Mar; 96(13):e6358. PubMed ID: 28353563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
